HBFOTC FILING WATCHBY HONGBO FINANCELIVE WIREOFFICIAL SEC RECORDS · FINRA OTC DAILY LIST
公司公告

Evofem Biosciences Effects Previously-Approved

Evofem Biosciences, Inc. · EVFM

原披露日期:;精度:秒。

来源:SEC(SEC EDGAR 8-K)。

查看原始披露 ↗

查看已提交的公告附件 ↗

融资准备壳资料工具

原文限定:Stockholders holding their shares electronically in book-entry form are not required to take any action to receive post-split shares. Stockholders owning shares through a bank, broker or other nominee will have their positions automatically adjusted to reflect the reverse stock split, subject to brokers' particular processes, and will not be required to take any action in connection with the reverse stock split. For those stockholders holding physical stock certificates, the Company's transfer agent, Pacific Stock Transfer, will send instructions for exchanging those certificates for shares held electronically in book-entry form or for new certificates, in either case representing the post-split number of shares, and any payments in cash in lieu of fractional shares, if applicable.

标题保留原文的计划、申请、条件、初步结果及否定状态,以原文为准。本站核验来源归属、证券身份及披露时间,不保证公司陈述或投资价值。

核验记录与处理时间

来源原始时间字段:2026-11-18T21:58:37.000Z;日期依据:SEC accepted filing time (Atom and index checked); calendar date is America/New_York; not an inferred press-release time。

采集层首次发现:2026-11-18T22:15:28.583Z;事件路径观察:2026-11-18T22:16:07.809Z。

处理开始:2026-11-19T01:16:04.086Z;处理完成:2026-11-19T01:16:05.596Z;首次资格通过:2026-11-19T01:16:05.596Z;首次公开:2026-11-19T01:16:05.596Z。

公开模式:natural_new;处理方式:automatic;规则版本:sec_company_events_v3_filed_release;自然时槽:2026-11-19T01:15:23.513Z。

保留原始披露及首次时间,重新展示不重写发布时间。

公司身份依据 · OTC市场依据

身份核验记录:2026-11-19T01:16:04.889Z;来源核验记录:2026-11-19T01:16:04.889Z。